透過您的圖書館登入
IP:3.144.27.148
  • 學位論文

以螢光劑修飾之 RGS 發展新的 Gα 蛋白質相關疾病之藥物篩選策略

Development of a new drug screening strategy using fluorescent probe modified RGS (Regulator of G protein signaling) and Gα proteins

指導教授 : 楊啟伸

摘要


異三元體 G-蛋白質系統由 α、β、γ 三個次單元體所組成,參與將細胞外訊息藉由 G-蛋白質偶合受體 (G-protein-coupled receptor) 傳遞到細胞內的過程。RGS (regulator of G protein signaling) 是一種 GAP 蛋白質 (GTPase-accelerating proteins),可和 Gα 次單元體作用並活化其本身之 GTPase 活性,在 G-protein 系統中可加速關閉訊息的傳遞。在近幾年的研究中,RGS 蛋白質的重要性逐漸提高,特別是在心血管及神經系統方面,因此許多製藥學的研究主要都是集中在影響 RGS 的 GAP 活性上,期望能降低藥物的副作用及加強其使用效率。所以需要能大量進行藥物篩選的方法來偵測 GAP 活性的效率。 本實驗中,使用 Lucifer yellow 此螢光劑標定之 RGS4-box (RGS4 之功能性區域),即時監測其與 Gαi1 之間的作用。在所建立之 96 孔微量滴定盤分析結果顯示,Gα 處於活化態時,可觀測到約 17% 的螢光上升,確定以此螢光試劑作為篩選的方法是可產生專一且足夠的訊號。

並列摘要


Heterotimeric G-protein system consists of Gα and Gβγ subunits, and it involves in the signal transferring and amplification from GPCR (G-protein-coupled receptor) to cell inside. RGS (regulator of G protein signaling) protein functions as a GAP (GTPase-accelerating protein) by interacting and stimulating the intrinsic GTPase activity of specific Gα subunit and consequently accelerates the termination of the signal transition in G-protein system. Recently, the importance of RGS proteins is escalating, especially in the cardiovascular and nerve systems; many pharmacological studies currently focus on the GAP activity of RGS that potentially can reduce side effects or enhance drug efficiency. The need to have a high throughput drug screening method to detect GAP activity efficiencies becomes obvious. Here, we report a method that use a fluorescent probe, lucifer yellow, modified RGS4-box (the GAP functional domain of RGS4) to real-time monitor its interaction with Gαi1 protein. Our results show that a 17% fluorescence increase upon Gα activation can be reported by this fluorescent probe and the amplitude of this signal change is practically significant enough for reagent screening purpose when it is performed in a 96-well Reader setup.

並列關鍵字

Heterotimeric G-protein RGS GAP Lucifer yellow fluorescence

參考文獻


1. Ajit, S.K. & Young, K.H. Analysis of chimeric RGS proteins in yeast for the functional evaluation of protein domains and their potential use in drug target validation. Cell Signal 17, 817-25 (2005).
2. Bansal, G., Druey, K.M. & Xie, Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther 116, 473-95 (2007).
3. Barker, S.A., Wang, J., Sierra, D.A. & Ross, E.M. RGSZ1 and Ret RGS: two of several splice variants from the gene RGS20. Genomics 78, 223-9 (2001).
4. Berman, D.M., Kozasa, T. & Gilman, A.G. The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J Biol Chem 271, 27209-12 (1996).
5. Beyer, C.E. et al. Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo. Brain Res 1022, 214-20 (2004).

被引用紀錄


林千佳(2011)。以螢光修飾與嵌合蛋白質發展RGS調節因子篩選平台〔碩士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2011.02686

延伸閱讀